DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
暂无分享,去创建一个
Aneeka M Hancock | J. Jankovic | T. Montine | D. Galasko | J. Quinn | E. Peskind | G. Baird | Min Shi | Jing Zhang | J. Leverenz | U. Kang | C. Zabetian | K. Chung | Hyejin Hwang | C. Pan | P. Jensen | Kathryn A. Chung | Joshua M. Bradner | Zhen Hong
[1] T. Beach,et al. Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients , 2009, Molecular Neurodegeneration.
[2] S. Chen,et al. Phosphoproteome study reveals Hsp27 as a novel signaling molecule involved in GDNF-induced neurite outgrowth. , 2009, Journal of proteome research.
[3] K. Blennow,et al. Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss? , 2009, Neuroscience Letters.
[4] R. Melis,et al. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. , 2009, Journal of Alzheimer's disease : JAD.
[5] B. Mollenhauer,et al. Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration , 2008, Experimental Neurology.
[6] O. Sydow,et al. Cerebellar αsynuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Shengdi Chen,et al. Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. , 2008, Journal of proteome research.
[8] W. F. Abdo,et al. A more efficient enzyme-linked immunosorbent assay for measurement of α-synuclein in cerebrospinal fluid , 2008, Journal of Neuroscience Methods.
[9] H. Ariga,et al. Secretion of DJ-1 into the serum of patients with Parkinson's disease , 2008, Neuroscience Letters.
[10] E. Masliah,et al. Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease , 2007, Neuroscience Letters.
[11] Jing Zhang,et al. Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells , 2007, BMC Neuroscience.
[12] M. Horne,et al. Plasma α-synuclein is decreased in subjects with Parkinson's disease , 2007, Experimental Neurology.
[13] M. Horne,et al. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease. , 2007, Experimental neurology.
[14] T. Tokuda,et al. Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease. , 2006 .
[15] J. Wiltfang,et al. Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia , 2006, Dementia and Geriatric Cognitive Disorders.
[16] E. Masliah,et al. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. , 2006, Biochemical and biophysical research communications.
[17] M. Cameron Sullards,et al. Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases* , 2006, Journal of Biological Chemistry.
[18] D. Allsop,et al. Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] K. Blennow,et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.
[20] T. Tokuda,et al. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. , 2006, Biochemical and biophysical research communications.
[21] P. Lee,et al. The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy , 2006, Journal of Neural Transmission.
[22] P. Wadhwa,et al. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. , 2005, Journal of reproductive immunology.
[23] R. Barker,et al. Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's disease , 2005, Neuroscience Letters.
[24] N. Bonini,et al. DJ‐1 is present in a large molecular complex in human brain tissue and interacts with α‐synuclein , 2005, Journal of neurochemistry.
[25] R. Barker,et al. Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease. , 2005, Neuroscience letters.
[26] C. Tanner,et al. Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.
[27] P. Højrup,et al. Proteasomal Inhibition by α-Synuclein Filaments and Oligomers* , 2004, Journal of Biological Chemistry.
[28] P. Højrup,et al. Proteasomal inhibition by alpha-synuclein filaments and oligomers. , 2004, The Journal of biological chemistry.
[29] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[30] L. Golbe. Alpha-synuclein and Parkinson's disease. , 2003, Advances in neurology.
[31] D. Burn,et al. Progressive supranuclear palsy: where are we now? , 2002, The Lancet Neurology.
[32] C. Masters,et al. Platelet α- and γ-synucleins in Parkinson's disease and normal control subjects , 2002 .
[33] C. Masters,et al. Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects. , 2002, Journal of Alzheimer's disease : JAD.
[34] J Q Trojanowski,et al. Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.
[35] D. Vignali. Multiplexed particle-based flow cytometric assays. , 2000, Journal of immunological methods.
[36] M. Tabaton,et al. Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects , 2000, Neuroscience Letters.
[37] F. Amenta,et al. LOCALIZATION OF DOPAMINE RECEPTOR SUBTYPES IN SYSTEMIC ARTERIES , 2000, Clinical and experimental hypertension.
[38] M. Tabaton,et al. Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. , 2000, Neuroscience letters.